219 studies found for:    Open Studies | "Urinary Bladder Neoplasms"
Show Display Options
Rank Status Study
21 Unknown  Screening for Bladder Cancer
Condition: Bladder Cancer
Intervention: Other: Specimen and questionnaires only
22 Unknown  Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer
Condition: Bladder Cancer
Interventions: Biological: BCG solution;   Biological: recombinant interferon alfa;   Drug: epirubicin hydrochloride;   Drug: mitomycin C;   Other: laboratory biomarker analysis;   Procedure: hyperthermia treatment;   Procedure: quality-of-life assessment
23 Recruiting VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer
Condition: Bladder Cancer
Intervention: Drug: VPM1002BC
24 Recruiting Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging
Condition: Bladder Cancer
Interventions: Procedure: Tissue Biopsy;   Procedure: Magnetic Resonance Imaging (MRI)
25 Unknown  Phase I & II Trial of Intravesicular Abraxane for Treatment-refractory Bladder Cancer
Condition: Bladder Cancer
Intervention: Drug: Paclitaxel, nanoparticle albumin-bound
26 Recruiting Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer
Conditions: Carcinoma, Non-Small-Cell Lung;   Urinary Bladder Neoplasms
Intervention: Drug: Carbon-14-labeled carboplatin
27 Recruiting Surgery With or Without Postoperative Intensity Modulated Radiation Therapy in Treating Patients With Urothelial Bladder Cancer
Conditions: Stage III Bladder Cancer;   Stage IV Bladder Cancer
Interventions: Other: No radiation;   Radiation: Intensity-Modulated Radiation Therapy
28 Unknown  Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer
Conditions: Bladder Cancer;   Carcinoma, Transitional Cell
Intervention: Drug: gemcitabine
29 Recruiting Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Drug: mitomycin C
30 Recruiting Biomarker Identification for Bladder Cancer Patients
Condition: Bladder Cancer
Intervention: Procedure: Sample Collection
31 Unknown  Genetic Susceptibility to Bladder Cancer
Conditions: Bladder Cancer;   Healthy
Intervention: Other: Specimens, personal and follow-up telephone interviews
32 Recruiting Risk of Bladder Cancer in Type 2 Diabetes Patients With Pioglitazone Therapy "PROBE"
Condition: Bladder Cancer
Intervention: Drug: Pioglitazone
33 Recruiting Enzalutamide for Bladder Cancer Chemoprevention
Condition: Bladder Cancer
Intervention: Drug: Enzalutamide
34 Not yet recruiting Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder Staging
Condition: Muscle-invasive Bladder Cancer
Intervention: Other: Whole-body FDG PET-CT
35 Not yet recruiting FIRBladd - Use of Infrared Spectroscopy in the Diagnosis of Bladder Tumors
Condition: Bladder Cancer
Intervention: Other: Urine infrared analysis
36 Recruiting PET/MRI and Biomarkers in Bladder Cancer
Condition: Bladder Cancer
Intervention: Device: MRI/acetate-PET imaging
37 Unknown  Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer
Conditions: Hematuria;   Bladder Cancer
Intervention: Drug: Valproic Acid
38 Not yet recruiting Metformin and Simvastatin Use in Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: Metformin;   Drug: Simvastatin
39 Not yet recruiting Detection of K14 in Bladder Cancer With a Non Invasive Technique
Condition: Bladder Cancer
40 Recruiting Fluorescence Cystoscopy and Optimized MMC in Recurrent Bladder Cancer (FinnBladder 9)
Condition: Bladder Cancer
Interventions: Procedure: white light TUR-BT;   Procedure: blue light TUR-BT;   Drug: optimized MMC;   Drug: single immediate chemotherapy instillation

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years